Has John Ciciarelli received payments from drug or device companies?

Yes. Drug and device makers reported $26,997 in general payments to John Ciciarelli across 1,745 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Ciciarelli did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Ciciarelli come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Ciciarelli

Internal Medicine · Oakhurst, NJNPI 1629085691

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 1,745 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,997in general payments, 2019–2025

Across 1,745 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$4K
AstraZeneca$3K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
AbbVie$2K
Amgen$2K
Johnson & Johnson$2K
plus $13K from 37 others

What the payments were for

Food & beverage$26,938100%
Education$580%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	234	$3,512
AstraZeneca	131	$2,854
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	179	$2,414
AbbVie(2 entities)	165	$2,402
Amgen(2 entities)	117	$1,682
Johnson & Johnson	85	$1,601
Pfizer	103	$1,366
Sanofi-aventis U.S. LLC	72	$1,161
GSK	61	$1,156
Arbor Pharmaceuticals, Inc.	93	$1,065
Takeda Pharmaceuticals U.S.A., Inc.	90	$1,001
Boehringer Ingelheim	68	$923
Lilly USA, LLC	67	$855
Kowa Pharmaceuticals America, Inc.	62	$840
Amarin Pharma, Inc.	38	$595
Abbott	27	$521
Bayer	22	$519
Merck	34	$459
E.r. Squibb & Sons, L.L.C.	8	$411
Biohaven Pharmaceutical Holding Company Ltd.	12	$304
Esperion Therapeutics, Inc.	9	$225
Novartis	14	$213
Exact Sciences	10	$152
Eisai Inc.	10	$139
Genentech USA, Inc.	4	$138
Medtronic	1	$88
Mannkind Corporation	4	$54
Sanofi Pasteur Inc.	4	$54
Lundbeck LLC	3	$40
Radius Health, Inc.	3	$40
Biohaven Pharmaceuticals, Inc.	2	$29
Hikma Pharmaceuticals USA	2	$26
Nevro Corp.	1	$21
Corcept Therapeutics	1	$17
Azurity Pharmaceuticals, Inc.	1	$15
Astellas Pharma US Inc	1	$15
Zyla Life Sciences, Inc.	1	$14
QOL Medical, LLC	1	$13
Dynavax Technologies Corporation	1	$13
Medicure Pharma Inc.	1	$13
Vertical Pharmaceuticals, LLC	1	$12
Almatica Pharma LLC	1	$12
Daiichi Sankyo Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,997 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	35	$446
Rosuvastatin Calcium	25	$331
Atorvastatin Calcium	25	$319
Olmesartan Medoxomil	11	$263
Losartan Potassium	11	$217
Amlodipine Besylate	22	$193
Metformin Hcl ErMetformin Hcl	11	$189
Metoprolol Succinate	13	$159
Levothyroxine Sodium	13	$155
Escitalopram Oxalate	14	$155
Simvastatin	14	$127

Paid to pharmacies, not to this prescriber.

Other internal medicine in Oakhurst

David ShulkinMorristown$1.7M
Howard UdermanLakewood$955K
Darshi SunderamEast Orange$530K
Annika DrongeEmerson$401K
Stephen MarcellaNew Brunswick$331K
Viju VijaysadanKinnelon$325K
Mark MonaneWoodcliff Lake$268K
Martin BedigianLivingston$240K
Rameck HuntPlainsboro$217K
Angel LazoSecaucus$195K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →